Hak-Bong Kim

Involvement of SIRT1 in hypoxic down-regulation of c-Myc and β-catenin and hypoxic preconditioning effect of polyphenols

Kyung-Soo Hong, Jun-Ik Park, Mi‐Ju Kim et al. · Toxicology and Applied Pharmacology · 2012 · 48 citations

Biochemistry, Redox Regulator, Medicine +6

TRAIL sensitize MDR cells to MDR-related drugs by down-regulation of P-glycoprotein through inhibition of DNA-PKcs/Akt/GSK-3β pathway and activation of caspases

Suk-Bin Seo, Jung-Gu Hur, Mi‐Ju Kim et al. · Molecular Cancer · 2010 · 44 citations · Full text

Sensitization of Chemo-Resistant Human Chronic Myeloid Leukemia Stem-Like Cells to Hsp90 Inhibitor by SIRT1 Inhibition

Hak-Bong Kim, Su-Hoon Lee, Jee‐Hyun Um et al. · International Journal of Biological Sciences · 2015 · 41 citations · Full text

Immunology, Cancer Biology, Tumor Biology +17

Amurensin G, a novel SIRT1 inhibitor, sensitizes TRAIL-resistant human leukemic K562 cells to TRAIL-induced apoptosis

Hak-Bong Kim, Mi‐Ju Kim, Su-Hoon Lee et al. · Biochemical Pharmacology · 2012 · 37 citations

Medicine, Apoptosis, Immunology +10

Trichostatin A sensitizes human ovarian cancer cells to TRAIL-induced apoptosis by down-regulation of c-FLIPL via inhibition of EGFR pathway

Soo-Jung Park, Mi‐Ju Kim, Hak-Bong Kim et al. · Biochemical Pharmacology · 2009 · 34 citations

Oncogenic Agent, Medicine, Cell Death +9